Ratings by Mizuho Securities (Vamil Divan)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/24/2021 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
6/22/2021 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
6/22/2021 Satsuma Pharmaceuticals STSA Upgrade Buy
(Neutral)
5.62
(6.60)
17.44% Details
6/15/2021 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
5/28/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
5/11/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
5/6/2021 Pfizer PFE Downgrade Neutral
(Buy)
39.95
(39.19)
-1.9% Details
5/6/2021 Evolus EOLS Upgrade Buy
(Neutral)
9.01
(13.85)
53.72% Details
5/5/2021 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
5/3/2021 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
4/28/2021 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
4/26/2021 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
4/26/2021 Neurocrine Bio. NBIX Maintain Neutral
(N/A)
 
 
  Details
4/26/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
4/26/2021 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
4/12/2021 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
4/6/2021 Acadia Pharmaceuticals ACAD Downgrade Neutral
(Buy)
25.59
(25.01)
-2.27% Details
4/5/2021 Satsuma Pharmaceuticals STSA Maintain Neutral
(N/A)
 
 
  Details
4/1/2021 ContraFect Corp. CFRX Maintain Neutral
(N/A)
 
 
  Details
3/31/2021 ContraFect Corp. CFRX Maintain Buy
(N/A)
 
 
  Details
3/30/2021 Evolus EOLS Maintain Neutral
(N/A)
 
 
  Details
3/17/2021 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
3/12/2021 Acadia Pharmaceuticals ACAD Maintain Buy
(N/A)
 
 
  Details
3/8/2021 Eli Lilly LLY Maintain Buy
(Buy)
 
 
  Details
3/2/2021 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
3/2/2021 Axsome Therapeutics AXSM Maintain Buy
(N/A)
 
 
  Details
3/1/2021 Acadia Pharmaceuticals ACAD Maintain Neutral
(N/A)
 
 
  Details
2/26/2021 Karuna Therapeutics Inc. KRTX Maintain Buy
(N/A)
 
 
  Details
2/26/2021 Sage Therapeutics SAGE Downgrade Neutral
(Buy)
85.04
(57.01)
-32.96% Details
2/5/2021 Neurocrine Bio. NBIX Maintain Neutral
(N/A)
 
 
  Details
2/4/2021 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
2/3/2021 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
2/1/2021 Eli Lilly LLY Maintain Buy
(N/A)
 
 
  Details
1/18/2021 Eli Lilly LLY Upgrade Buy
(Neutral)
186.69
(232.97)
24.79% Details
1/7/2021 Alkermes ALKS Maintain Buy
(N/A)
 
 
  Details
12/17/2020 Sage Therapeutics SAGE Maintain Buy
(N/A)
 
 
  Details
12/16/2020 Eli Lilly LLY Maintain Neutral
(N/A)
 
 
  Details
12/16/2020 Axsome Therapeutics AXSM New Coverage Buy
(N/A)
79.95
(70.51)
-11.81% Details
12/16/2020 Acadia Pharmaceuticals ACAD New Coverage Buy
(N/A)
52.13
(25.01)
-52.02% Details
12/4/2020 Sage Therapeutics SAGE Upgrade Buy
(Neutral)
68.57
(57.01)
-16.86% Details
11/13/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
11/12/2020 Pfizer PFE Maintain Buy
(Buy)
 
 
  Details
11/11/2020 Satsuma Pharmaceuticals STSA Maintain Neutral
(N/A)
 
 
  Details
11/6/2020 Sage Therapeutics SAGE Maintain Neutral
(N/A)
 
 
  Details
10/15/2020 Alkermes ALKS Upgrade Buy
(Neutral)
17.27
(24.52)
41.98% Details
8/19/2020 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
7/23/2020 Neurocrine Bio. NBIX Maintain Neutral
(N/A)
 
 
  Details
7/20/2020 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
7/7/2020 Evolus EOLS Downgrade Neutral
(Buy)
5.32
(13.85)
160.34% Details
7/1/2020 Pfizer PFE Maintain Buy
(N/A)
 
 
  Details
6/24/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
6/10/2020 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
6/10/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
6/4/2020 Neurocrine Bio. NBIX Maintain Neutral
(N/A)
 
 
  Details
5/22/2020 Evolus EOLS Maintain Buy
(N/A)
 
 
  Details
5/18/2020 Pfizer PFE Maintain Buy
(Buy)
 
 
  Details
5/6/2020 Abbvie ABBV Maintain Buy
(Buy)
 
 
  Details
5/4/2020 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
4/27/2020 Pfizer PFE Maintain Buy
(Buy)
 
 
  Details
4/22/2020 Eli Lilly LLY Maintain Neutral
(Neutral)
 
 
  Details
3/18/2020 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
2/11/2020 Eli Lilly LLY Maintain Neutral
(Neutral)
 
 
  Details
2/11/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
2/10/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
2/10/2020 Biohaven Pharmaceutical Holding BHVN Maintain Buy
(N/A)
 
 
  Details
2/10/2020 Abbvie ABBV Maintain Buy
(N/A)
 
 
  Details
2/6/2020 Neurocrine Bio. NBIX New Coverage Neutral
(N/A)
103.10
(100.58)
-2.44% Details
2/6/2020 Pfizer PFE New Coverage Buy
(N/A)
37.69
(39.19)
3.98% Details
2/6/2020 Evolus EOLS New Coverage Buy
(N/A)
10.39
(13.85)
33.3% Details
2/6/2020 Sage Therapeutics SAGE New Coverage Neutral
(N/A)
67.28
(57.01)
-15.26% Details
2/6/2020 Biohaven Pharmaceutical Holding BHVN New Coverage Buy
(N/A)
52.44
(97.27)
85.49% Details
2/6/2020 Alkermes ALKS New Coverage Neutral
(N/A)
17.52
(24.52)
39.95% Details
2/6/2020 Abbvie ABBV New Coverage Buy
(N/A)
84.36
(114.74)
36.01% Details
2/6/2020 Karuna Therapeutics Inc. KRTX New Coverage Buy
(N/A)
93.02
(127.32)
36.87% Details
2/5/2020 Eli Lilly LLY New Coverage Neutral
(N/A)
143.44
(186.69)
30.15% Details